Notably, dimerized PKM2 has been reported to bind to the promoter of Programmed Cell Death-Ligand 1 (PD-L1), resulting in a significant increase of PD-L1 expression, thereby facilitating immune evasion by cancer cells11. Here, CD274 is linked to cancer.